Catalog No.:AA009G3Q

1350925-22-2 | 3,6-Dichloropyrido[2,3-b]pyrazine

Name: Name:3,6-Dichloropyrido[2,3-b]pyrazine
Brand: AABLOCKS
SKU: AA009G3Q
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

95%

in stock

$715.00 $500.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA009G3Q

Chemical Name:

3,6-Dichloropyrido[2,3-b]pyrazine

CAS Number:

1350925-22-2

Molecular Formula:

C7H3Cl2N3

Molecular Weight:

200.0248

MDL Number:

MFCD15144630

SMILES:

Clc1ccc2c(n1)nc(cn2)Cl

Properties

Downstream Synthesis Route

110-91-8

1350925-22-2

1362739-76-1

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2011/149937,2011,A1Locationinpatent:Page/Pagecolumn41;86

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2013/78441,2013,A1Locationinpatent:Paragraph00143;00332-00333

[3]CurrentPatentAssignee:OTSUKAHOLDINGSCOLTD-WO2013/61080,2013,A1Locationinpatent:Page/Pagecolumn171;172

[4]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2014/151147,2014,A1Locationinpatent:Paragraph00641

[5]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2015/30588,2015,A1Locationinpatent:Page/Pagecolumn66

[6]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US9295673,2016,B2Locationinpatent:Page/Pagecolumn341;342

40851-95-4

1350925-22-2

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2011/149937,2011,A1

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2013/78441,2013,A1

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2014/151147,2014,A1

[4]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2015/30588,2015,A1

[5]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US9295673,2016,B2

[6]Aikawa;Yano;Nakatani[OrganicandBiomolecularChemistry,2017,vol.15,#6,p.1313-1316]

146015-42-1

1350925-22-2

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2011/149937,2011,A1

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2013/78441,2013,A1

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2014/151147,2014,A1

[4]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2015/30588,2015,A1

[5]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US9295673,2016,B2

1350925-19-7

1350925-22-2

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2011/149937,2011,A1

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2013/78441,2013,A1

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2014/151147,2014,A1CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US9295673,2016,B2

[4]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2015/30588,2015,A1

[5]Aikawa;Yano;Nakatani[OrganicandBiomolecularChemistry,2017,vol.15,#6,p.1313-1316]

1350925-20-0

1350925-22-2

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2011/149937,2011,A1

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2013/78441,2013,A1

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2014/151147,2014,A1CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US9295673,2016,B2

[4]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2015/30588,2015,A1

[5]Aikawa;Yano;Nakatani[OrganicandBiomolecularChemistry,2017,vol.15,#6,p.1313-1316]

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country: